Literature DB >> 12930575

Luteinizing hormone affects uterine receptivity independently of ovarian function.

Jan Tesarik1, André Hazout, Carmen Mendoza.   

Abstract

Previous studies have suggested that LH, in addition to its well-known effects on the ovary, may exert direct effects on the uterus. This study evaluated the effects of mid-cycle administration of human chorionic gonadotrophin (HCG), which signals through the LH receptor, on endometrial thickness and uterine receptivity in two groups of women lacking ovarian activity and receiving embryos from an oocyte donation programme. Patients in one group still had ovulatory cycles, but their ovarian function was suppressed by pituitary down-regulation with a gonadotrophin-releasing hormone (GnRH) agonist in the embryo transfer cycle, resulting in low endogenous LH concentrations. Patients in the other group were menopausal women whose pituitary function was not down-regulated in the embryo transfer cycle and whose endogenous LH concentrations were thus high. Patients in each of the two groups were randomized into two subgroups. Patients in one subgroup were given 5000 IU of HCG 2 days before oocyte recovery in the corresponding donor. Patients in the other subgroup received placebo at the same time. Oocytes from each donor were randomly distributed between one patient from the HCG subgroup and one patient from the placebo subgroup in each patient group. Endometrial growth and secretory transformation were stimulated by sequential treatment with oestradiol valerate and progesterone. In women with low endogenous LH receiving placebo, endometrial thickness stopped increasing at the beginning of secretory transformation. Mid-cycle HCG administration resulted in a continuous increase in endometrial thickness through this period, improved the implantation rate after embryo transfer in these women (30.6 versus 20.7%) and augmented the number of multiple pregnancies. No similar stagnation of endometrial thickness and no effects of mid-cycle HCG administration on endometrial thickness, the implantation rate and the number of multiple pregnancies were found in women with high endogenous LH. It is concluded that endometrial maturation is disturbed in women with low endogenous LH but can be rescued by mid-cycle stimulation of LH receptor with exogenous HCG in the absence of ovarian activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930575     DOI: 10.1016/s1472-6483(10)61729-4

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  32 in total

1.  Periovulatory increases in tissue homing potential of circulating CD56(bright) cells are associated with fertile menstrual cycles.

Authors:  Marianne J van den Heuvel; Julie Horrocks; Siamak Bashar; Kota Hatta; Suzanne Burke; Sharon S Evans; B Anne Croy; Francis R Tekpetey
Journal:  J Clin Endocrinol Metab       Date:  2005-03-22       Impact factor: 5.958

2.  The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome.

Authors:  Atsushi Yanaihara; Takeshi Yorimitsu; Hiroshi Motoyama; Motohiro Ohara; Toshihiro Kawamura
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

Review 3.  Endometrial responses to embryonic signals in the primate.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

4.  Assessing predictors for the success of GnRH antagonist protocol in reproductive women in IVF/ICSI - in fresh cycles.

Authors:  An-Cong Wang; Ying Wang; Feng-Xia Wu; Dong-Yi Zhu
Journal:  Biomed Rep       Date:  2017-09-14

Review 5.  The role of FOXO1 in the decidual transformation of the endometrium and early pregnancy.

Authors:  Takeshi Kajihara; Jan J Brosens; Osamu Ishihara
Journal:  Med Mol Morphol       Date:  2013-02-05       Impact factor: 2.309

6.  Polycystic ovary syndrome and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Julie R Palmer; Elizabeth A Stewart; Lynn Rosenberg
Journal:  Fertil Steril       Date:  2007-01-22       Impact factor: 7.329

7.  Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol.

Authors:  Kyono Koichi; Nakajo Yukiko; Kumagai Shima; Sasaki Sachiko
Journal:  J Assist Reprod Genet       Date:  2006-06-20       Impact factor: 3.412

8.  Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation.

Authors:  Suxia Bai; Gail Grossman; Lingwen Yuan; Bruce A Lessey; Frank S French; Steven L Young; Elizabeth M Wilson
Journal:  Mol Hum Reprod       Date:  2007-11-29       Impact factor: 4.025

9.  Reduced FSH and LH action: implications for medically assisted reproduction.

Authors:  E Bosch; C Alviggi; M Lispi; A Conforti; A C Hanyaloglu; D Chuderland; M Simoni; N Raine-Fenning; P Crépieux; S Kol; V Rochira; T D'Hooghe; P Humaidan
Journal:  Hum Reprod       Date:  2021-05-17       Impact factor: 6.918

10.  Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Alessandro Conforti; Sandro C Esteves; Peter Humaidan; Salvatore Longobardi; Thomas D'Hooghe; Raoul Orvieto; Alberto Vaiarelli; Danilo Cimadomo; Laura Rienzi; Filippo Maria Ubaldi; Fulvio Zullo; Carlo Alviggi
Journal:  Reprod Biol Endocrinol       Date:  2021-06-21       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.